Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Exchange Rate Effect: 2020-2025

Historic Exchange Rate Effect for Arrowhead Pharmaceuticals (ARWR) over the last 6 years, with Sep 2025 value amounting to -$401,000.

  • Arrowhead Pharmaceuticals' Exchange Rate Effect fell 100.55% to -$24,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$401,000, marking a year-over-year decrease of 109.55%. This contributed to the annual value of -$401,000 for FY2025, which is 109.55% down from last year.
  • According to the latest figures from FY2025, Arrowhead Pharmaceuticals' Exchange Rate Effect is -$401,000, which was down 109.55% from $4.2 million recorded in FY2024.
  • In the past 5 years, Arrowhead Pharmaceuticals' Exchange Rate Effect registered a high of $4.2 million during FY2024, and its lowest value of -$401,000 during FY2025.
  • Moreover, its 3-year median value for Exchange Rate Effect was -$122,000 (2023), whereas its average is $1.2 million.
  • Per our database at Business Quant, Arrowhead Pharmaceuticals' Exchange Rate Effect crashed by 121.46% in 2021 and then surged by 3,540.16% in 2024.
  • Arrowhead Pharmaceuticals' Exchange Rate Effect (Yearly) stood at -$88,000 in 2021, then grew by 23.86% to -$67,000 in 2022, then plummeted by 82.09% to -$122,000 in 2023, then spiked by 3,540.16% to $4.2 million in 2024, then crashed by 109.55% to -$401,000 in 2025.